Search

Displaying results 3001 - 3010 of 9886 in total
  1. Drug

    Iolopride I-123

    go.drugbank.com/drugs/DB20028
    Experimental

    Iolopride I-123 has a monoisotopic molecular weight of 400.06 Da. … Iolopride I-123 is a small molecule drug. The usage of the INN stem '-pride' in the name indicates that Iolopride I-123 is a sulpiride derivative and analogue.

    Categories: Compounds used in a research, industrial, or household setting
  2. Drug

    Urefibrate

    go.drugbank.com/drugs/DB20849
    Experimental

    Urefibrate has a monoisotopic molecular weight of 354.02 Da. … Urefibrate is a small molecule drug.

  3. Drug

    Sitofibrate

    go.drugbank.com/drugs/DB21192
    Experimental

    Sitofibrate has a monoisotopic molecular weight of 610.42 Da. … Sitofibrate is a small molecule drug.

  4. Drug

    Ninerafaxstat

    go.drugbank.com/drugs/DB21486
    Investigational

    Ninerafaxstat has a monoisotopic molecular weight of 415.21 Da. … Ninerafaxstat is a small molecule drug.

  5. Drug

    Ebaresdax

    go.drugbank.com/drugs/DB21496
    Investigational

    Ebaresdax has a monoisotopic molecular weight of 266.07 Da. … Ebaresdax is a small molecule drug.

  6. Drug

    Razpipadon

    go.drugbank.com/drugs/DB21542
    Investigational

    Razpipadon has a monoisotopic molecular weight of 389.12 Da. … Razpipadon is a small molecule drug.

  7. Drug

    Zatonacaftor

    go.drugbank.com/drugs/DB21625
    Experimental

    Zatonacaftor has a monoisotopic molecular weight of 453.17 Da. … Zatonacaftor is a small molecule drug.

  8. Drug

    Zibrofusidic acid

    go.drugbank.com/drugs/DB20799
    Investigational

    Zibrofusidic acid has a monoisotopic molecular weight of 594.26 Da. … Zibrofusidic acid is a small molecule drug.

  9. Drug

    Evixapodlin

    go.drugbank.com/drugs/DB21520
    Investigational

    Evixapodlin has a monoisotopic molecular weight of 690.22 Da. … Evixapodlin is a small molecule drug.

  10. Drug

    L-Glutamine

    go.drugbank.com/drugs/DB00130
    ApprovedInvestigationalNutraceutical

    An oral formulation of L-glutamine was approved by the FDA in July 2017 for use in sickle cell disease [L892]. This oral formulation is marketed under the tradename Endari by Emmaus Medical. … A non-essential amino acid present abundantly throughout the body and is involved in many metabolic processes. It is synthesized from glutamic acid and ammonia.

    Synonyms: L-Glutamin, L-GlutamineInternational brands: L-Glutamine Power